← Back to Clinical Trials
Recruiting NCT07157358

NCT07157358 Online Medical Hypnosis Exercises to Improve Mental Health in Primary School Children and Prevent Future Mental Health Issues

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07157358
Status Recruiting
Phase
Sponsor St. Antonius Hospital
Condition Healty Volunteers
Study Type INTERVENTIONAL
Enrollment 345 participants
Start Date 2025-07-31
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
standardized audio hypnosis recordings for healthy children at primary school

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 345 participants in total. It began in 2025-07-31 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this trial is to learn if listening daily to online hypnosis exercises helps to improve mental health and self-esteem in primary school children. In the future we also hope to see if it can prevent feelings of depession or anxiety when these children have become teenagers. The main questions it aims to answer are: 1. can daily listening to these exercsies improve self-esteem, resilience and mental health of children 10-11 years compared to children who do not listen to these exercises? 2. can listening to these exercsies prevent future metal health problems like feelings of depression or anxiety. Researchers will compare a group of children (10-11 years) who will listen daily to the exercises for 2 months with a group who will do that 6 months later. Participants will: Listen daily to a hypnosis exercise of maximum 15 minutes. Fill out questionnaires on self-esteem, resilience and mental health before during and after the study.

Eligibility Criteria

Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Fluent in Dutch 2. Attending group 6 or 7 of a regular primary school in the Netherlands 3. Permission of the parents to listen daily to one of the Breinbaas hypnosis exercises (maximum 20 minutes per day) 4. Access to an electronic device to listen to the Breinbaas exercises (phone, tablet, computer) - Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Children treated with hypnotherapy in the three years preceding potential inclusion 2. Children currently receiving psychological treatment

Contact & Investigator

Central Contact

Shelley van der Veek, PhD

✉ sveek@fsw.leidenuniv.nl

📞 0031-715273767

Principal Investigator

Arine M Vlieger, MD,PhD

PRINCIPAL INVESTIGATOR

St. Antonius Hospital

Frequently Asked Questions

Who can join the NCT07157358 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying Healty Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07157358 currently recruiting?

Yes, NCT07157358 is actively recruiting participants. Contact the research team at sveek@fsw.leidenuniv.nl for enrollment information.

Where is the NCT07157358 trial being conducted?

This trial is being conducted at Leiden, Netherlands.

Who is sponsoring the NCT07157358 clinical trial?

NCT07157358 is sponsored by St. Antonius Hospital. The principal investigator is Arine M Vlieger, MD,PhD at St. Antonius Hospital. The trial plans to enroll 345 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology